Abstract
Neurotoxicity is a common complication during cancer chemotherapy. It is estimated that 3–10% of children with acute lymphoblastic leukemia (ALL) experience acute, transient neurotoxicity during induction chemotherapy. Fatal acute neurotoxicity is rarely encountered. Neurological evaluation of children with ALL at diagnosis and during treatment is of value in order to diagnose neurological complications early so that appropriate intervention can be adopted. This communication describes the profile of two children with unexpected, acute fatal neurologic toxicity during induction chemotherapy for ALL.
This is a preview of subscription content, log in via an institution to check access.
References
Craft AW. Childhood cancer — mainly curable so where next?Acta Pediatr 2000; 89: 386–393.
Macdonald DR. Neurologic complications of chemotherapy.Neurol Clin 1991; 9: 955–967.
Campbell RH, Marshall WC, Chessells JM. Neurological complications of childhood leukaemia.Arch Dis Child 1977; 52: 850–858.
Dimario Jr. FJ, Packer RJ. Acute mental status changes in children with systemic cancer.Pediatrics 1990; 85: 353–360.
Mena H, Garcia JH, Velandia F. Central peripheral myelinopathy associated with systemic neoplasia and chemotherapy.Cancer 1981; 48: 1724–1737.
Legha SS. Vincristine neurotoxicity. Pathophysiology and management.Med Toxicol 1986; 1: 421–427.
Sandier SG, Tobin W, Henderson S. Vincristine induced neuropathy.Neurology 1969; 19: 367–374.
McCarthy GM, Skilling JR. A prospective cohort study of the orofacial effects of vincristine neurotoxicity.J Oral Pathol 1991; 20: 345–349.
Soysal T, Ferhanoglu T, Bilir A, Akman L. Oculomotor nerve palsy associated with vincristine treatment.Acta Haematol 1993; 90: 209–210.
Byrd RL, Rohrbaugh TM, Raney RB Jr, Norris DG. Transient cortical blindness secondary to vincristine therapy in childhood malignancies.Cancer 1981; 47: 37–40.
Desai ZR, VandenBerg HW, Bridges JM, Shanks RG. Can severe neurotoxicity be prevented?Cancer Chemother Pharmacol 1982; 8: 211–214.
Jackson DV, Wells HB, Atkins JN, Zekan PJ, White DR, Richards F, Cruz JM, Muss HB. Amelioration of vincristine neurotoxicity by glutamic acid.Am J Med 1988; 84: 1016–1022.
Houi H, Mochio S, Kobayashi T. Gangliosides attenuate vincristine neurotoxicity on dorsal root ganglion cells.Muscle Nerve 1993; 16: 11–14.
Kiburg B, Moorer van Delft CM, Heimans JJ, Hujgens PC, Boer HH.In vivo modulation of vincristine induced neurotoxicity in Lymnaea stagnalis, by the ACTH analogue Org 2766.J Neuro Oncol 1996; 30: 173–180.
Young SB. Nursing considerations in caring for the child with vincristine induced neurotoxicities.J Pediatr Oncol Nurs 1990; 7: 9–13
Winick NJ, Bowman WP, Kamen BA, Roach ES, Rollins N, Jacaruso D, Buchanan GR. Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia.J Natl Cancer Inst 1992; 84: 252–256.
Chen CY, Zimmerman RA, Faro S, Bilniuk LT, Chou TY, Molloy PT. Childhood leukemia: central nervous system abnormalities during and after treatment.Am J Neuroradiol 1996; 17: 295–310.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ray, M., Marwaha, R.K. & Trehan, A. Chemotherapy related fatal neurotoxicity during induction in acute lymphoblastic leukemia. Indian J Pediatr 69, 185–187 (2002). https://doi.org/10.1007/BF02859383
Issue Date:
DOI: https://doi.org/10.1007/BF02859383